マーケットレポート詳細
マイクロキャリアの世界市場：製品別、用途別2028年予測
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Culture Vessel, Filtration), Consumables (Media, Reagent), Beads (Collagen, Cationic), Application (Vaccine, Cell & Gene Therapy), End User - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年 12月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文412ページになります。
- 商品コード：MAM3476
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
マイクロキャリアの世界市場規模は2023年で20億ドル、2028年に33億ドル、市場の平均年成長率は10.0%に到達する見込みです。
レポートはマイクロキャリアの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（14社）、エコシステム分析、ファイブフォース分析などの分析も加味し、マイクロキャリア市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆マイクロキャリアの世界市場予測2021-2028年
・市場規模(US$)
◆製品別、市場-2028年
消耗品
・培地
-血清培地
-無血清培地
-その他培地
・試薬
・マイクロキャリアビーズ
-コラーゲンコーティングビーズ
-カチオンビーズ
-タンパク質コーティングビーズ
-未処理ビーズ
-その他のマイクロキャリアビーズ
装置
・バイオリアクター
-ステンレス製バイオリアクター
-シングルユースバイオリアクター
・培養容器
・ろ過/分離装置
・セルカウンター
・その他装置
※(市場規模US$)
◆用途別、市場-2028年
バイオ医薬品生産
・ワクチン生産
・治療用タンパク質生産
・組織工学/再生医療
＜治療タイプ別＞
-細胞/遺伝子治療
-その他組織工学/再生医療
＜細胞タイプ別＞
-幹細胞
-免疫細胞
-その他細胞タイプ
その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・製薬、バイオテクノロジー企業
・受託研究機関/受託製造機関
・学術研究機関
・細胞バンク
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・中東
・アフリカ
※国地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・ファイブフォース分析
・エコシステム分析
・サプライチェーン分析
・バリューチェーン分析
・技術分析
・特許分析
・主要なステークホルダーと購買基準
・市場シェア分析
・競合状況
◆マイクロキャリアの主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC INC.
・SARTORIUS AG
・DANAHER CORPORATION
・MERCK KGAA
・CORNING INCORPORATED
・富士フイルムホールディングス株式会社
・BECTON, DICKINSON AND COMPANY (BD)
・EPPENDORF SE
・LONZA
・GETINGE AB
・CHEMOMETEC
・ESCO LIFESCIENCES GROUP LTD.
・ENTEGRIS
・BBI-BIOTECH GMBH
（その他企業）
・STEMCELL TECHNOLOGIES
・STOBBE GROUP
・DISTEK, INC.
・BIONET
・G&G TECHNOLOGIES, INC.
・TANTTI
・KÜHNER AG
・PBS BIOTECH, INC.
・REPROCELL INC.
・MEISSNER FILTRATION PRODUCTS, INC.
・SMART MCS PTY LTD
（全412頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SEGMENTATION
1.3.1 MARKET SCOPE
1.3.2 YEARS CONSIDERED 56
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 LIMITATIONS 57
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 2 MICROCARRIERS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 3 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022)
・ FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
・ FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS (2022)
2.2.1 INSIGHTS FROM PRIMARIES
・ FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
・ FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH FORECAST
・ FIGURE 8 MICROCARRIERS MARKET: CAGR PROJECTIONS
・ FIGURE 9 MICROCARRIERS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
・ TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 11 MICROCARRIERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 MICROCARRIERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 MICROCARRIERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICROCARRIERS MARKET
4 PREMIUM INSIGHTS
4.1 MICROCARRIERS MARKET OVERVIEW
・ FIGURE 15 INCREASING DEMAND FOR CELL-BASED VACCINES TO DRIVE MARKET DURING FORECAST PERIOD
4.2 NORTH AMERICA: MICROCARRIERS MARKET, BY PRODUCT
・ FIGURE 16 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 MICROCARRIERS MARKET, BY END USER
・ FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 MICROCARRIERS MARKET, BY APPLICATION
・ FIGURE 18 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 MICROCARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 19 ASIA PACIFIC SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 20 MICROCARRIERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 MICROCARRIERS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 GROWING ADOPTION OF MICROCARRIERS FOR CELL-BASED VACCINE PRODUCTION
5.2.1.2 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MICROCARRIER-BASED CELL PRODUCTION
5.2.1.3 RISING INVESTMENTS IN CELL & GENE THERAPY RESEARCH
・ TABLE 5 FUNDING INVESTMENTS IN CELL & GENE THERAPY
・ FIGURE 21 TOTAL FUNDING INCURRED THROUGH SERIES A AND SEED FINANCINGS FOR GENE, CELL, AND RNA THERAPY COMPANIES (Q2 2022−Q2 2023) (USD MILLION)
5.2.1.4 GROWING PREFERENCE FOR SINGLE-USE TECHNOLOGIES
5.2.1.5 INCREASING R&D SPENDING FOR BIOPHARMACEUTICAL PRODUCTION
・ FIGURE 22 PHARMACEUTICAL R&D SPENDING (USD BILLION) (2014–2028)
5.2.2 RESTRAINTS
5.2.2.1 HIGH COST OF CELL BIOLOGY RESEARCH
5.2.2.2 LIMITATIONS IN HIGH-DENSITY CELL CULTURE PRODUCTION
5.2.3 OPPORTUNITIES
5.2.3.1 RISING DEMAND FOR 3D CELL CULTURE
5.2.3.2 GROWING DEMAND FOR MABS AND BIOSIMILARS
・ TABLE 6 MABS APPROVED FOR THERAPEUTIC USE BY US FDA (2021–2023)
・ FIGURE 23 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012−2022)
・ FIGURE 24 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015−2023)
5.2.3.3 HIGH-GROWTH POTENTIAL OF EMERGING ECONOMIES
5.2.4 CHALLENGES
5.2.4.1 HIGH COSTS ASSOCIATED WITH SERUM-FREE MEDIA
5.2.4.2 MICROCARRIER-CELL DETACHMENT
5.3 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 7 MICROCARRIERS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 ECOSYSTEM ANALYSIS
・ TABLE 8 MICROCARRIERS MARKET: ROLE IN ECOSYSTEM
5.5 SUPPLY CHAIN ANALYSIS
・ FIGURE 25 MICROCARRIERS MARKET: SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
・ FIGURE 26 MICROCARRIERS MARKET: VALUE CHAIN ANALYSIS
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3 REGULATORY SCENARIO
・ TABLE 13 MICROCARRIERS MARKET: REGULATORY GUIDELINES
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE OF MICROCARRIER EQUIPMENT AND CONSUMABLES
・ TABLE 14 AVERAGE SELLING PRICE OF MICROCARRIER CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER (USD)
5.8.2 AVERAGE SELLING PRICE OF MICROCARRIER PRODUCTS, BY REGION
・ TABLE 15 AVERAGE SELLING PRICE OF MICROCARRIER CELL CULTURE PRODUCTS, BY REGION (USD)
・ TABLE 16 AVERAGE SELLING PRICE OF SINGLE-USE ASSEMBLIES, BY REGION (USD)
5.9 TECHNOLOGICAL ANALYSIS
5.9.1 SINGLE-USE TECHNOLOGIES
・ TABLE 17 COMPARISON OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
5.9.2 MICROCARRIER BEADS
5.10 PATENT ANALYSIS
・ FIGURE 27 PATENTS GRANTED IN MICROCARRIERS MARKET (JANUARY 2013– OCTOBER 2023)
・ TABLE 18 INDICATIVE LIST OF PATENTS IN MICROCARRIERS MARKET
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024
・ TABLE 19 MICROCARRIERS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
・ FIGURE 28 REVENUE SHIFT & NEW POCKETS FOR MICROCARRIER PROVIDERS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCARRIERS
5.13.2 BUYING CRITERIA FOR END USERS
・ FIGURE 30 KEY BUYING CRITERIA FOR END USERS
6 MICROCARRIERS MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 20 MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 CONSUMABLES 119
・ TABLE 21 CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 22 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 23 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 24 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 25 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 26 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 27 CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.2.1 MEDIA
・ TABLE 28 MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 29 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 30 EUROPE: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 31 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 32 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 33 MIDDLE EAST & AFRICA: MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 34 MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.2.1.1 SERUM-BASED MEDIA
6.2.1.1.1 WIDE USAGE IN RESEARCH & BIOPHARMA APPLICATIONS TO FUEL MARKET
・ TABLE 35 SERUM-BASED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 36 NORTH AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 37 EUROPE: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 38 ASIA PACIFIC: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 39 LATIN AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 MIDDLE EAST & AFRICA: SERUM-BASED MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.2 SERUM-FREE MEDIA
6.2.1.2.1 RISING DEMAND FOR REGENERATIVE MEDICINE TO PROPEL MARKET
・ TABLE 41 SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 42 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 43 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 44 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 45 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 46 MIDDLE EAST & AFRICA: SERUM-FREE MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.3 OTHER MEDIA
・ TABLE 47 OTHER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 48 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 49 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 51 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 52 MIDDLE EAST & AFRICA: OTHER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 REAGENTS
6.2.2.1 ABILITY TO MAINTAIN CELL METABOLISM AND PROTECT TISSUES FROM DAMAGE TO DRIVE MARKET
・ TABLE 53 REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 54 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 55 EUROPE: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 56 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 57 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 MIDDLE EAST & AFRICA: REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3 MICROCARRIER BEADS
・ TABLE 59 MICROCARRIER BEADS OFFERED, BY KEY PLAYER
・ TABLE 60 MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 61 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 EUROPE: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 65 MIDDLE EAST & AFRICA: MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 66 MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.2.3.1 COLLAGEN-COATED BEADS
6.2.3.1.1 DEVELOPMENT OF NEW COLLAGEN-COATED MICROCARRIERS TO SUPPORT MARKET GROWTH
・ TABLE 67 COLLAGEN-COATED MICROCARRIER PRODUCTS OFFERED, BY KEY PLAYER
・ TABLE 68 COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 EUROPE: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 ASIA PACIFIC: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 72 LATIN AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 73 MIDDLE EAST & AFRICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3.2 CATIONIC BEADS
6.2.3.2.1 ABILITY TO ENHANCE CELL INTERACTION TO BOOST DEMAND
・ TABLE 74 CATIONIC MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 75 NORTH AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 76 EUROPE: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 77 ASIA PACIFIC: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 78 LATIN AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 MIDDLE EAST & AFRICA: CATIONIC MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3.3 PROTEIN-COATED BEADS
6.2.3.3.1 ETHICAL IMPERATIVES AND REGULATORY COMPLIANCE TO DRIVE MARKET
・ TABLE 80 PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 81 NORTH AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 82 EUROPE: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 83 ASIA PACIFIC: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 84 LATIN AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 85 MIDDLE EAST & AFRICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3.4 UNTREATED BEADS
6.2.3.4.1 LOW-CELL ATTACHMENT EFFICIENCY TO RESTRAIN MARKET
・ TABLE 86 UNTREATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 87 NORTH AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 88 EUROPE: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 ASIA PACIFIC: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 90 LATIN AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 91 MIDDLE EAST & AFRICA: UNTREATED MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3.5 OTHER MICROCARRIER BEADS
・ TABLE 92 OTHER MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 93 NORTH AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 94 EUROPE: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 ASIA PACIFIC: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 LATIN AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 97 MIDDLE EAST & AFRICA: OTHER MICROCARRIER BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.4 OTHER CONSUMABLES 154
・ TABLE 98 OTHER CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 99 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 100 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 101 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 102 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 103 MIDDLE EAST & AFRICA: OTHER CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 EQUIPMENT 157
・ TABLE 104 EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 105 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 106 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 108 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 109 MIDDLE EAST & AFRICA: EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 110 EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.3.1 BIOREACTORS
・ TABLE 111 BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 112 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 113 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 114 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 115 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 116 MIDDLE EAST & AFRICA: BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 117 BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
6.3.1.1 STAINLESS-STEEL BIOREACTORS
6.3.1.1.1 UTILIZATION IN LARGE-SCALE MANUFACTURING OF PHARMACEUTICAL DRUGS TO DRIVE MARKET
・ TABLE 118 STAINLESS-STEEL BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 119 NORTH AMERICA: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 120 EUROPE: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 121 ASIA PACIFIC: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 122 LATIN AMERICA: STAINLESS-STEEL BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 123 MIDDLE EAST & AFRICA: STAINLESS-STEEL BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1.2 SINGLE-USE BIOREACTORS
6.3.1.2.1 LOWER OPERATIONAL COSTS AND INCREASED FLEXIBILITY TO BOOST DEMAND
・ TABLE 124 LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER
・ TABLE 125 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 126 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 127 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 128 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 129 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 130 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 CULTURE VESSELS 168
6.3.2.1 DEVELOPMENT OF 3D DYNAMIC CELL CULTURE SYSTEMS TO DRIVE MARKET
・ TABLE 131 CULTURE VESSELS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 132 NORTH AMERICA: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 133 EUROPE: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 134 ASIA PACIFIC: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 135 LATIN AMERICA: CULTURE VESSELS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 136 MIDDLE EAST & AFRICA: CULTURE VESSELS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 FILTRATION & SEPARATION EQUIPMENT
6.3.3.1 GROWING USE IN BIOPROCESSING INDUSTRY TO BOOST DEMAND
・ TABLE 137 FILTRATION SYSTEMS OFFERED, BY KEY PLAYER
・ TABLE 138 FILTRATION & SEPARATION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 139 NORTH AMERICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 140 EUROPE: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 141 ASIA PACIFIC: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 142 LATIN AMERICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 143 MIDDLE EAST & AFRICA: FILTRATION & SEPARATION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 CELL COUNTERS
6.3.4.1 GROWING ADOPTION OF AUTOMATED CELL COUNTERS TO PROPEL MARKET
・ TABLE 144 CELL COUNTERS OFFERED, BY KEY PLAYER
・ TABLE 145 CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 146 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 147 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 148 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 149 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 150 MIDDLE EAST & AFRICA: CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.5 OTHER EQUIPMENT 178
・ TABLE 151 OTHER EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 152 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 153 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 154 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 155 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 156 MIDDLE EAST & AFRICA: OTHER EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
7 MICROCARRIERS MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 157 MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 BIOPHARMACEUTICAL PRODUCTION
・ TABLE 158 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 159 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 160 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 161 ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 162 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 163 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 164 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 VACCINE PRODUCTION
7.2.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO FUEL MARKET
・ TABLE 165 MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 166 NORTH AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 167 EUROPE: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 168 ASIA PACIFIC: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 169 LATIN AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 170 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
7.2.2 THERAPEUTIC PROTEIN PRODUCTION
7.2.2.1 GROWING PIPELINE FOR INNOVATIVE THERAPEUTICS TO SUPPORT MARKET 189
・ TABLE 171 MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 172 NORTH AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 191
・ TABLE 173 EUROPE: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 174 ASIA PACIFIC: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 175 LATIN AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 176 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)
7.2.3 TISSUE ENGINEERING AND REGENERATIVE MEDICINE
7.2.3.1 TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE 193
・ FIGURE 31 REGENERATIVE MEDICINE INVESTMENTS (2017−2023)
・ TABLE 177 MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 178 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 179 EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 180 ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 181 LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 182 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 183 MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
7.2.3.1.1 CELL & GENE THERAPY
7.2.3.1.1.1 RISING CLINICAL TRIALS FOR GENETIC DISORDERS AND CANCER TO DRIVE MARKET
・ TABLE 184 MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 185 NORTH AMERICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 186 EUROPE: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 187 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 188 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 189 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY REGION, 2021–2028 (USD MILLION)
7.2.3.1.2 OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS
・ TABLE 190 MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 191 NORTH AMERICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 192 EUROPE: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 193 ASIA PACIFIC: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 194 LATIN AMERICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 195 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR OTHER TISSUE ENGINEERING AND REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
7.2.3.2 TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY CELL TYPE
・ TABLE 196 TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY CELL TYPE, 2021–2028 (USD MILLION)
7.2.3.2.1 STEM CELLS
7.2.3.2.1.1 RISING ACTIVITIES IN STEM CELL RESEARCH TO FUEL MARKET
・ TABLE 197 MICROCARRIERS MARKET FOR STEM CELLS, BY TYPE, 2021–2028 (USD MILLION)
7.2.3.2.2 IMMUNE CELLS
7.2.3.2.2.1 INCREASING USAGE OF MICROCARRIERS FOR CAR-T CELL THERAPY TO BOOST DEMAND
・ TABLE 198 MICROCARRIERS MARKET FOR IMMUNE CELLS, BY TYPE, 2021–2028 (USD MILLION)
7.2.3.2.3 OTHER CELL TYPES
7.3 OTHER APPLICATIONS
・ TABLE 199 MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 200 NORTH AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 201 EUROPE: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 202 ASIA PACIFIC: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 203 LATIN AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 204 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 MICROCARRIERS MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 205 MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 RISING DEMAND FOR MABS AND BIOSIMILARS TO DRIVE MARKET
・ TABLE 206 MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 207 NORTH AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 208 EUROPE: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 209 ASIA PACIFIC: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 210 LATIN AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 211 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT MANUFACTURING ORGANIZATIONS
8.3.1 PROVISION OF CONTRACT RESEARCH SERVICES TO BOOST DEMAND
・ TABLE 212 MICROCARRIERS MARKET FOR CROS AND CMOS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 213 NORTH AMERICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 214 EUROPE: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 215 ASIA PACIFIC: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 216 LATIN AMERICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 217 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CROS AND CMOS, BY REGION, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING COLLABORATIONS BETWEEN BIOPHARMACEUTICAL COMPANIES AND ACADEMIC INSTITUTES TO SUPPORT MARKET
・ TABLE 218 MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 219 NORTH AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 220 EUROPE: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 221 ASIA PACIFIC: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 222 LATIN AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 223 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
8.5 CELL BANKS 222
8.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE STEM CELL THERAPIES TO PROPEL MARKET
・ TABLE 224 MICROCARRIERS MARKET FOR CELL BANKS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 225 NORTH AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 226 EUROPE: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 227 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 228 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 229 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR CELL BANKS, BY REGION, 2021–2028 (USD MILLION)
9 MICROCARRIERS MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 230 MICROCARRIERS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 32 NORTH AMERICA: MICROCARRIERS MARKET SNAPSHOT
・ TABLE 231 NORTH AMERICA: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 232 NORTH AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 233 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 234 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 235 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 236 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 237 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 238 NORTH AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 239 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 240 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 241 NORTH AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 RISING REGULATORY APPROVALS FOR CELL & THERAPY PRODUCTS TO DRIVE MARKET
・ FIGURE 33 MARKET DEVELOPMENT FOR ADVANCED THERAPEUTIC MEDICINAL PRODUCTS (ATMPS) (USD BILLION) (EXCLUSIVE OF VACCINES)
・ TABLE 242 US: EXAMPLES OF LEADING SUCCESSFUL APPLICANTS IN CIRM’S TRANSLATIONAL PROGRAM
・ TABLE 243 US: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 244 US: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 245 US: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 246 US: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 247 US: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 248 US: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 249 US: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 250 US: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 251 US: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 252 US: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 RISING DEMAND FOR BIOLOGICS TO DRIVE MARKET
・ TABLE 253 CANADA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 254 CANADA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 255 CANADA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 256 CANADA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 257 CANADA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 258 CANADA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 259 CANADA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 260 CANADA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 261 CANADA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 262 CANADA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
・ TABLE 263 EUROPE: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 264 EUROPE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 265 EUROPE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 266 EUROPE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 267 EUROPE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 268 EUROPE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 269 EUROPE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 270 EUROPE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 271 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 272 EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 273 EUROPE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 RISING R&D INVESTMENTS IN LIFE SCIENCES RESEARCH TO PROPEL MARKET
・ TABLE 274 GERMANY: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 275 GERMANY: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 276 GERMANY: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 277 GERMANY: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 278 GERMANY: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 279 GERMANY: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 280 GERMANY: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 281 GERMANY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 282 GERMANY: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 283 GERMANY: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTICS TO BOOST DEMAND
・ TABLE 284 UK: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 285 UK: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 286 UK: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 287 UK: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 288 UK: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 289 UK: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 290 UK: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 291 UK: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 292 UK: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 293 UK: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 RISING FOCUS ON BIOTECH CLUSTERS TO BOOST DEMAND
・ TABLE 294 FRANCE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 295 FRANCE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 296 FRANCE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 297 FRANCE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 298 FRANCE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 299 FRANCE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 300 FRANCE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 301 FRANCE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 302 FRANCE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 303 FRANCE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 RISING DEMAND FOR THERAPEUTICS TO PROPEL MARKET
・ TABLE 304 ITALY: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 305 ITALY: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 306 ITALY: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 307 ITALY: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 308 ITALY: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 309 ITALY: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 310 ITALY: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 311 ITALY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 312 ITALY: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 313 ITALY: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 INCREASING DEMAND FOR BIOPHARMACEUTICALS TO SUPPORT MARKET GROWTH 264
・ TABLE 314 SPAIN: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 315 SPAIN: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 316 SPAIN: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 317 SPAIN: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 318 SPAIN: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 319 SPAIN: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 320 SPAIN: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 321 SPAIN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 322 SPAIN: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 323 SPAIN: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
・ TABLE 324 REST OF EUROPE: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 325 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 326 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 327 REST OF EUROPE: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 328 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 329 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 330 REST OF EUROPE: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 331 REST OF EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 332 REST OF EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 333 REST OF EUROPE: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
・ FIGURE 34 ASIA PACIFIC: MICROCARRIERS MARKET SNAPSHOT
・ TABLE 334 ASIA PACIFIC: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 335 ASIA PACIFIC: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 336 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 337 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 338 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 339 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 340 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 341 ASIA PACIFIC: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 342 ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 343 ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 344 ASIA PACIFIC: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 CHINA
9.4.1.1 GROWTH IN BIOPROCESSING INDUSTRY TO DRIVE MARKET
・ FIGURE 35 BIOPLAN SURVEY RESPONDENTS FOR ENTRY OF GLOBAL SUPPLIERS (2018−2021)
・ TABLE 345 CHINA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 346 CHINA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 347 CHINA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 348 CHINA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 349 CHINA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 350 CHINA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 351 CHINA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 352 CHINA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 353 CHINA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 354 CHINA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 FAVORABLE REGULATORY SUPPORT FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
・ TABLE 355 JAPAN: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 356 JAPAN: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 357 JAPAN: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 358 JAPAN: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 359 JAPAN: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 360 JAPAN: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 361 JAPAN: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 362 JAPAN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 363 JAPAN: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 364 JAPAN: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 RISING PHARMACEUTICAL R&D SPENDING TO PROPEL MARKET
・ TABLE 365 INDIA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 366 INDIA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 367 INDIA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 368 INDIA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 369 INDIA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 370 INDIA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 371 INDIA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 372 INDIA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 373 INDIA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 374 INDIA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 RISING DEMAND FOR BIOSIMILARS TO SUPPORT MARKET GROWTH
・ TABLE 375 SOUTH KOREA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 376 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 377 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 378 SOUTH KOREA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 379 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 380 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 381 SOUTH KOREA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 382 SOUTH KOREA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 383 SOUTH KOREA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 384 SOUTH KOREA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
・ TABLE 385 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 386 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 387 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 388 REST OF ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 389 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 390 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 391 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 392 REST OF ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 393 REST OF ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 394 REST OF ASIA PACIFIC: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.6 ASIA PACIFIC: RECESSION IMPACT
9.5 LATIN AMERICA
・ TABLE 395 LATIN AMERICA: MICROCARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 396 LATIN AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 397 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 398 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 399 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 400 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 401 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 402 LATIN AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 403 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 404 LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 405 LATIN AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 RISING FOCUS ON VACCINE DEVELOPMENT TO SUPPORT MARKET GROWTH
・ TABLE 406 BRAZIL: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 407 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 408 BRAZIL: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 409 BRAZIL: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 410 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 411 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 412 BRAZIL: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 413 BRAZIL: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 414 BRAZIL: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 415 BRAZIL: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 EXPANSION OF PHARMA & BIOPHARMA COMPANIES TO BOOST DEMAND
・ TABLE 416 MEXICO: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 417 MEXICO: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 418 MEXICO: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 419 MEXICO: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 420 MEXICO: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 421 MEXICO: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 422 MEXICO: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 423 MEXICO: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 424 MEXICO: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 425 MEXICO: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
・ TABLE 426 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 427 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 428 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 429 REST OF LATIN AMERICA: MICROCARRIERS BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 430 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 431 REST OF LATIN AMERICA: BIOREACTORS, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 432 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 433 REST OF LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 434 REST OF LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 435 REST OF LATIN AMERICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
・ TABLE 436 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 437 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 438 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 439 MIDDLE EAST & AFRICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 440 MIDDLE EAST & AFRICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 441 MIDDLE EAST & AFRICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 442 MIDDLE EAST & AFRICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 443 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 444 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 445 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 446 MIDDLE EAST & AFRICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.1 MIDDLE EAST
9.6.1.1 FAVORABLE GOVERNMENT INVESTMENTS FOR BIOTECH RESEARCH TO BOOST DEMAND
・ TABLE 447 MIDDLE EAST: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 448 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 449 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 450 MIDDLE EAST: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 451 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 452 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 453 MIDDLE EAST: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 454 MIDDLE EAST: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 455 MIDDLE EAST: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 456 MIDDLE EAST: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 AFRICA
9.6.2.1 RISING GOVERNMENT FOCUS ON CLINICAL TRIAL APPROVALS TO SUPPORT MARKET
・ TABLE 457 AFRICA: MICROCARRIERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 458 AFRICA: CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 459 AFRICA: MEDIA MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 460 AFRICA: MICROCARRIER BEADS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 461 AFRICA: EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 462 AFRICA: BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 463 AFRICA: MICROCARRIERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 464 AFRICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 465 AFRICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY THERAPY TYPE, 2021–2028 (USD MILLION)
・ TABLE 466 AFRICA: MICROCARRIERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ FIGURE 36 MICROCARRIERS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS
・ FIGURE 37 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROCARRIERS MARKET (2018–2022)
10.4 MARKET SHARE ANALYSIS
・ FIGURE 38 MICROCARRIERS MARKET SHARE, BY KEY PLAYER (2022)
・ TABLE 467 MICROCARRIERS MARKET: INTENSITY OF COMPETITIVE RIVALRY
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
・ FIGURE 39 MICROCARRIERS MARKET: COMPANY EVALUATION MATRIX (2022)
10.5.5 COMPANY FOOTPRINT ANALYSIS 338
・ TABLE 468 MICROCARRIERS MARKET: PRODUCT FOOTPRINT ANALYSIS (2022)
・ TABLE 469 MICROCARRIERS MARKET: REGIONAL FOOTPRINT ANALYSIS (2022)
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
・ FIGURE 40 MICROCARRIERS MARKET: START-UP/SME EVALUATION MATRIX (2022)
10.6.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES
・ TABLE 470 MICROCARRIERS MARKET: DETAILED LIST OF KEY START-UPS/SMES
・ TABLE 471 MICROCARRIERS MARKET: PRODUCT & REGIONAL FOOTPRINT ANALYSIS OF KEY START-UPS/SMES
10.7 COMPETITIVE SCENARIOS AND TRENDS
・ TABLE 472 MICROCARRIERS MARKET: KEY PRODUCT LAUNCHES (JANUARY 2020−OCTOBER 2023)
・ TABLE 473 MICROCARRIERS MARKET: KEY DEALS (JANUARY 2020−OCTOBER 2023)
・ TABLE 474 MICROCARRIERS MARKET: OTHER DEVELOPMENTS (JANUARY 2020−OCTOBER 2023)
11 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS) *
11.1 KEY PLAYERS 349
11.1.1 THERMO FISHER SCIENTIFIC INC.
・ TABLE 475 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
11.1.2 SARTORIUS AG
・ TABLE 476 SARTORIUS AG: BUSINESS OVERVIEW
・ FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2022)
11.1.3 DANAHER CORPORATION
・ TABLE 477 DANAHER CORPORATION: BUSINESS OVERVIEW
・ FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 MERCK KGAA
・ TABLE 478 MERCK KGAA: BUSINESS OVERVIEW
・ FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.5 CORNING INCORPORATED
・ TABLE 479 CORNING INCORPORATED: BUSINESS OVERVIEW
・ FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
11.1.6 FUJIFILM HOLDINGS CORPORATION
・ TABLE 480 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
・ FIGURE 46 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
11.1.7 BECTON, DICKINSON AND COMPANY (BD)
・ TABLE 481 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・ FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.8 EPPENDORF SE
・ TABLE 482 EPPENDORF SE: BUSINESS OVERVIEW
・ FIGURE 48 EPPENDORF SE: COMPANY SNAPSHOT (2022)
11.1.9 LONZA
・ TABLE 483 LONZA: BUSINESS OVERVIEW
・ FIGURE 49 LONZA: COMPANY SNAPSHOT (2022)
11.1.10 GETINGE AB
・ TABLE 484 GETINGE AB: BUSINESS OVERVIEW
・ FIGURE 50 GETINGE AB: COMPANY SNAPSHOT (2022)
11.1.11 CHEMOMETEC
・ TABLE 485 CHEMOMETEC: BUSINESS OVERVIEW
・ FIGURE 51 CHEMOMETEC: COMPANY SNAPSHOT (2022)
11.1.12 ESCO LIFESCIENCES GROUP LTD. 407
・ TABLE 486 ESCO LIFESCIENCES GROUP LTD.: BUSINESS OVERVIEW
11.1.13 ENTEGRIS
・ TABLE 487 ENTEGRIS: BUSINESS OVERVIEW 410
・ FIGURE 52 ENTEGRIS: COMPANY SNAPSHOT (2022)
11.1.14 BBI-BIOTECH GMBH
・ TABLE 488 BBI-BIOTECH GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 STEMCELL TECHNOLOGIES
・ TABLE 489 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
11.2.2 STOBBE GROUP
・ TABLE 490 STOBBE GROUP: BUSINESS OVERVIEW
11.2.3 DISTEK, INC.
・ TABLE 491 DISTEK, INC.: BUSINESS OVERVIEW
11.2.4 BIONET
・ TABLE 492 BIONET: BUSINESS OVERVIEW
11.2.5 G&G TECHNOLOGIES, INC. 419
・ TABLE 493 G&G TECHNOLOGIES, INC.: BUSINESS OVERVIEW
11.2.6 TANTTI
・ TABLE 494 TANTTI: BUSINESS OVERVIEW
11.2.7 KÜHNER AG
・ TABLE 495 KÜHNER AG: BUSINESS OVERVIEW 421
11.2.8 PBS BIOTECH, INC.
・ TABLE 496 PBS BIOTECH, INC.: BUSINESS OVERVIEW
11.2.9 REPROCELL INC.
・ TABLE 497 REPROCELL INC.: BUSINESS OVERVIEW
11.2.10 MEISSNER FILTRATION PRODUCTS, INC.
・ TABLE 498 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
11.2.11 SMART MCS PTY LTD
・ TABLE 499 SMART MCS PTY LTD: BUSINESS OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.